About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 18,983 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,983 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6461-6480 of 18,983 trials

CompletedClinical Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact LensThe purpose of this study is to assess the clinical performance of an investigational contact lens over 30 days of daily wear.NCT04476784·Maitland, Florida and 4 others CompletedEvaluation of Silicone Hydrogel Daily Wear Contact Lenses for Up to One (1) Month of Daily WearThe aim of the study is to evaluate if the performance of Invigor A is substantially equivalent to Invigor B contact lenses when used in a one month recommended replacement, daily…NCT03722784·Torrance, California and 5 others CompletedEvaluation of the GORE Conformable TAG® for Treatment of Traumatic TransectionTAG 08-02 is a prospective, multicenter, single-arm study to evaluate the use of the CTAG Device in traumatic transection of the descending thoracic aorta.NCT00917852·Los Angeles, California and 25 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

CompletedSafety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and CirrhosisThe primary objective of this study is to evaluate the efficacy, safety, and tolerability of treatment with sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) fixed-dose…NCT02639338·Long Beach, California and 69 others

TerminatedDysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1The purpose of this study is to provide confirmatory evidence of the safety and efficacy of two Dysport® (AbobotulinumtoxinA) doses (600 units \[U\] and 800 U), compared to…NCT02660138·Birmingham, Alabama and 80 others

CompletedENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety DisorderThe ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD)NCT05749055·Phoenix, Arizona and 31 others

CompletedA Study of the TAXUS Liberté Stent for the Treatment of de Novo Coronary Artery Lesions in Small VesselsTAXUS ATLAS Small Vessel is a global, multi-center, single-arm, trial of patients with coronary arteries less than 2.5 mm in diameter who are treated with the TAXUS Liberté stent…NCT00371748·Sacramento, California and 24 others

CompletedEribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung CancerThe purpose of this study is to determine whether Eribulin Mesylate Administered in Combination with Pemetrexed is safe and tolerable and to gain a preliminary indication of…NCT01126736·Tucson, Arizona and 17 others

CompletedStudy to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)The purpose of this study is to measure the rate of anti-palivizumab antibodies (also referred to as immune reactivity or immunogenicity) in subjects receiving either the liquid…NCT00233064·Birmingham, Alabama and 53 others

RecruitingGram-Negative Bloodstream Infection Oral Antibiotic Therapy TrialThe Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early transition to oral…NCT06080698·San Francisco, California and 10 others

RecruitingA Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid TumorsThis is a first-in-human Phase I/II, open-label, multicenter, dose-escalation and expansion study designed to evaluate the safety, pharmacokinetics, and preliminary activity of…NCT06619587·La Jolla, California and 42 others

Active not recruitingA Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)The purpose of this study is to compare the efficacy and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm B) in patients with CLL/SLL…NCT04965493·Chandler, Arizona and 175 others

RecruitingEffect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell DiseaseAcute vaso-occlusive crisis (VOC) is the most common complication in patients with sickle cell disease (SCD) and pain related to VOC is often inadequately treated.NCT03353584·Memphis, Tennessee and 1 other

CompletedREVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial InfarctionThe purpose of this study is to evaluate whether erythropoietin can help limit the damage to the heart in patients with acute heart attacks.NCT00378352·Washington D.C., District of Columbia and 15 others

CompletedA Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic NeuralgiaPregabalin is an alpha-2 delta ligand approved for the treatment of neuropathic pain, however, not all patients will respond to this drug.NCT00599638·Huntsville, Alabama and 38 others

CompletedPhase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With RosaceaPhase 3 efficacy and safety study of CD07805/47 topical gel in subjects with facial erythema associated with rosacea.NCT01355458·Los Angeles, California and 14 others

CompletedDoes Tension-Free Herniorrhaphy or Laparoscopic Herniorrhaphy Achieve Equal or Better Recurrence Rates and Lower Costs While Achieving Equivalent Outcomes for Hernia Patients?Inguinal hernia is one of the most common worldwide afflictions of men. The presence of an inguinal hernia is indication for its repair.NCT00032448·Birmingham, Alabama and 13 others

TerminatedThis Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureThe study will evaluate the efficacy and safety of LCZ696 compared to enalapril on morbidity and mortality in patients with chronic heart failure (NYHA Class II - IV and EF =\<…NCT01035255·Birmingham, Alabama and 1030 others

CompletedTo Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.NCT00141336·Phoenix, Arizona and 102 others

CompletedProstate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation TherapyDutasteride inhibits the conversion of testosterone to dihydrotestosterone (DHT) the male hormone that leads to benign prostate growth.NCT00470834·Homewood, Alabama and 61 others

PreviousPage 324 of 950Next

Diabetes

in Tennessee

Heart Diseasein Tennessee